Read more: Zepbound KwikPen: How to use it and what makes it different Managing tirzepatide injection site issues A small amount of redness, itching, bruising, or soreness after an injection is fairly common with tirzepatide
XGFR is a bispecific antibody that was developed to target EGFR and IGF-1R and has shown some promise in pre-clinical studies of metastatic osteosarcoma (Gvozdenovic et al., 2017)
This depends on the plan and the provider
If side effects resolve but you notice no benefits by month three, the product may not be right for your biology
Not for human consumption, veterinary use, diagnostic use, or therapeutic purposes
Your body initially targets fat for the most part, but it's typical for some energy to come from muscle reserves too